Hypertension and Nephrology

Loading the player...

2018 Guideline on the Management of Blood Cholesterol

Sidney C. Smith, MD, past president of the American Heart Association, and Neil J. Stone, MD discuss the new 2018 Guideline on the Management of Blood Cholesterol, which was published during Scientific Sessions 2018 in Chicago.

2017 Hypertension Clinical Guidelines

  • This guideline is an update of the National Heart, Lung, and Blood Institute publication, “The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure” (JNC 7) and is a comprehensive resource for the clinical and public health practice communities.
  • Previous guidelines identified high blood pressure as ≥ 140/90 mm Hg. This guideline now defines high blood pressure to be anyone with a systolic blood pressure (SBP) ≥ 130 mm Hg or diastolic blood pressure (DBP) ≥ 80 mm Hg.
  • The change will mean more patients are diagnosed with hypertension. To improve blood pressure control and reduce cardiovascular disease (CVD) risk in these patients, a small percentage of them will be asked to take medications while the majority will be recommended for nonpharmacological interventions with healthy lifestyle changes.

See the full Science News coverage for the 2017 Hypertension Clinical Guidelines

Related Councils

Council on Hypertension

Karen A. Griffin, MD, FAHA, FASH, FASN, FACP

The mission of the Council on Hypertension is "to foster excellence in hypertension research and education" in order to achieve the American Heart Association?s goal ?to be a relentless force for a world of longer, healthier lives." Hypertension remains a world-wide public-health challenge and is a leading cause of stroke, heart disease, and the progression of chronic kidney disease.

Karen A. Griffin, MD, FAHA, FASH, FASN, FACP
Chair, Council on Hypertension

Hypertension Scientific Sessions       Hypertension       Hypertension Council Awards

Council on the Kidney in Cardiovascular Disease (KCVD)

Vivek Bhalla, MD, FASN, FAHA

The American Heart Association (AHA) Council on the Kidney in Cardiovascular Disease (KCVD) mission is to reduce cardiovascular-related disability and death through research, communication, advocacy and education about the kidney.

Kidney disease is a major cause and a consequence of cardiovascular disease. Chronic renal insufficiency is thought to be an independent risk factor for developing hypertension, vascular disease, atherosclerosis and other morbidity and mortality risk factors. Patients with cardiovascular disease and diabetes are also at high risk for developing kidney failure.

Vivek Bhalla, MD, FASN, FAHA
Chair, Council on the Kidney in Cardiovascular Disease

Hypertension Scientific Sessions       Hypertension       KCVD Council Awards

Council on Cardiovascular and Stroke Nursing (CVSN)

Nancy T. Artinian, PhD, RN, FAHA, FPCNA, FAAN

It is an honor and privilege to serve as Chair of the Council on Cardiovascular and Stroke Nursing (CVSN). I am looking forward to working with all of you to build upon what previous leaders have accomplished.

Nancy T. Artinian, PhD, RN, FAHA, FPCNA, FAAN
Chair, Council on Cardiovascular and Stroke Nursing
 

Scientific Sessions      International Stroke Conference       Journal of Cardiovascular Nursing       CVSN Council Awards